| anal | analgesia, analgesic; analysis, analytic |
|---|---|
| ANAL, anal | analgesia, analgesic; analysis, analytic |
| ANCOVA | analysis of covariance |
| ANOV, ANOVA | analysis of variance |
| AVA | activity vector analysis; antiviral antibody; aortic valve area; aortic valve atresia; arteriovenous... |
| human clinical trial | <pharmacology> Controlled clinical studies in human volunteers to test the safety and efficacy of pharmaceutical candidates. There are usually three distinct phases of human clinical testing: Phases I, II, and III. Phase I trials are safety studies of volunteers, usually healthy controls. Phase II trials are studies to confirm safety and study optimum dose and initial efficacy. Phase III trials are studies to prove safety and efficacy in a specific patient population. (14 Nov 1997) |
|---|---|
| disease, clinical | A disease with clinical signs and symptoms that can be recognised. As distinct from a subclinical illness without recognizable clinical manifestations. Diabetes, for example, can be subclinical in a person before emerging as a clinical disease. (12 Dec 1998) |
| in clinical parlance | The term often refers to the posterior funiculus of the spinal cord. (05 Mar 2000) |
| epidemiology, clinical | Epidemiology focused specifically upon patients. (12 Dec 1998) |
| accumulation analysis | A technique in which an intermediate of a metabolic pathway accumulates due to selective inhibition of a particular step in that pathway or in a mutant that is deficient in a certain step. The intermediate is then isolated, analyzed, and identified. (05 Mar 2000) |
| activation analysis | <radiobiology> Method for identifying and measuring chemical elements in a sample of material. Sample is first made radioactive by bombardment with neutrons, charged particles, or gamma rays. Newly formed radioactive atoms in the sample then give off characteristic radiations (such as gamma rays) that tell what kinds of atoms are present, and how many. (09 Oct 1997) |
| actuarial analysis | The application of probability and statistical methods to calculate the risk of occurrence of any event, such as onset of illness, recurrent disease, hospitalization, disability, or death. It may include calculation of the anticipated money costs of such events and of the premiums necessary to provide for payment of such costs. (12 Dec 1998) |
| amino acid analysis | Determination and identification of amino acid content of a macromolecule, identification of a specific amino acid in macromolecules, often a mutated protein, identification and quantitation of amino acid content in blood plasma or urine; a key diagnostic aid. (05 Mar 2000) |
| analysis | <technique> The separation into component parts or elements, the act of determining the component parts of a substance. Origin: Gr. Lysis = dissolution (18 Nov 1997) |
| analysis of variance | A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. (12 Dec 1998) |
| base sequence analysis | <molecular biology> A method, sometimes automated, for determining the base sequence. (09 Oct 1997) |
| bite analysis | A study of the relations of the occlusal surfaces of opposing teeth and their effect upon related structures. Synonym: bite analysis. (05 Mar 2000) |
| blood gas analysis | <investigation> A test which analyses arterial blood for oxygen, carbon dioxide and bicarbonate content in addition to blood pH. Used to test the effectiveness of respiration. (27 Sep 1997) |
| bradykinetic analysis | The analysis of a movement by means of slow cinematography. (05 Mar 2000) |
| breath analysis test | A test of hepatic and intestinal absorptive function; aminopyrine labelled with radioactive carbon is administered orally; expired 14CO2 is a measure of aminopyrine absorption and its metabolism in the liver; a measurement of the amount of 14CO2 exhaled after an oral dose of 14C-O-xylose; a measurement of exhaled hydrogen gas following an oral dose of lactose as a test of lactose deficiency. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|